China DNA Tester BGI-Shenzhen To Buy U.S. Test Maker For $117.6 Million
This article was originally published in PharmAsia News
Executive Summary
BGI-Shenzhen, which owns several genome-sequencing centers in China, has reached agreement to pay $117.6 million for U.S.-based Complete Genomics to enter the U.S. market for DNA testing.